H. Lundbeck AS (LTS:0ND5) Accounts Payable : kr4,188 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Accounts Payable?

H. Lundbeck AS's Accounts Payable for the quarter that ended in Mar. 2024 was kr4,188 Mil.

H. Lundbeck AS's quarterly Accounts Payable increased from Sep. 2023 (kr4,065 Mil) to Dec. 2023 (kr4,410 Mil) but then declined from Dec. 2023 (kr4,410 Mil) to Mar. 2024 (kr4,188 Mil).

H. Lundbeck AS's annual Accounts Payable increased from Dec. 2021 (kr3,914 Mil) to Dec. 2022 (kr4,251 Mil) and increased from Dec. 2022 (kr4,251 Mil) to Dec. 2023 (kr4,410 Mil).

H. Lundbeck AS Accounts Payable Historical Data

The historical data trend for H. Lundbeck AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Accounts Payable Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

3,933.00

3,740.00

3,914.00

4,251.00

4,410.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															3,787.00	4,052.00	4,065.00	4,410.00	4,188.00

H. Lundbeck AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

H. Lundbeck AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines